Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company ... The maximum tolerated dose (MTD) of Supinoxin has not yet been achieved. Three dosing cycles have been completed (25, 50 and 100 mg) and no drug related adverse ... ...

28 people liked this